Zymergen Inc. Operating Cash Flow
Zymergen Inc. reported Operating Cash Flow of -$99.58 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-08-15
- Zymergen Inc. net cash provided by (used in) operating activities for the quarter ending 2022-06-30 was -$54.83M.
- Zymergen Inc. net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was -$44.74M.
- Zymergen Inc. net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was -$64.83M.
- Zymergen Inc. net cash provided by (used in) operating activities for the quarter ending 2021-09-30 was -$70.54M.
- Zymergen Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$302.46M.
- Zymergen Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$223.20M.
- Zymergen Inc. net cash provided by (used in) operating activities for fiscal 2019 was -$195.56M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$54.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$99.58M 10-Q · filed 2022-08-15 | -$164.40M derived: sum of 3 quarters · filed 2022-08-15 | -$234.94M derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | -$44.74M 10-Q · filed 2022-05-12 | -$109.57M derived: sum of 2 quarters · filed 2022-05-12 | -$180.10M derived: sum of 3 quarters · filed 2022-05-12 | -$264.16M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-12-31 | -$64.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$135.36M derived: sum of 2 quarters · filed 2022-03-30 | -$219.42M derived: sum of 3 quarters · filed 2022-08-15 | -$302.46M 10-K · filed 2022-03-30 |
| 2021-09-30 | -$70.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$154.59M derived: sum of 2 quarters · filed 2022-08-15 | -$237.64M 10-Q · filed 2021-11-15 | -$299.65M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-06-30 | -$84.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$167.10M 10-Q · filed 2022-08-15 | -$229.12M derived: sum of 3 quarters · filed 2022-08-15 | -$272.55M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$83.05M 10-Q · filed 2022-05-12 | -$145.06M derived: sum of 2 quarters · filed 2022-05-12 | -$188.49M derived: sum of 3 quarters · filed 2022-05-12 | -$243.32M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$62.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$105.45M derived: sum of 2 quarters · filed 2022-03-30 | -$160.27M derived: sum of 3 quarters · filed 2022-03-30 | -$223.20M 10-K · filed 2022-03-30 |
| 2020-09-30 | -$43.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$98.26M derived: sum of 2 quarters · filed 2021-11-15 | -$161.19M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$54.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$117.75M 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | -$62.93M 10-Q · filed 2021-05-27 | |||
| 2019-12-31 | -$195.56M 10-K · filed 2022-03-30 |